[go: up one dir, main page]

AU5755500A - Isolated genes from virulent group B streptococcus agalactiae - Google Patents

Isolated genes from virulent group B streptococcus agalactiae

Info

Publication number
AU5755500A
AU5755500A AU57555/00A AU5755500A AU5755500A AU 5755500 A AU5755500 A AU 5755500A AU 57555/00 A AU57555/00 A AU 57555/00A AU 5755500 A AU5755500 A AU 5755500A AU 5755500 A AU5755500 A AU 5755500A
Authority
AU
Australia
Prior art keywords
streptococcus agalactiae
isolated genes
virulent
group
virulent group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU57555/00A
Inventor
Elisabeth Adderson
John Bohnsack
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Utah Research Foundation Inc
Original Assignee
University of Utah Research Foundation Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Utah Research Foundation Inc filed Critical University of Utah Research Foundation Inc
Publication of AU5755500A publication Critical patent/AU5755500A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU57555/00A 1999-06-21 2000-06-21 Isolated genes from virulent group B streptococcus agalactiae Abandoned AU5755500A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14008499P 1999-06-21 1999-06-21
US60/140084 1999-06-21
PCT/US2000/017082 WO2000078787A1 (en) 1999-06-21 2000-06-21 ISOLATED GENES FROM VIRULENT GROUP B $i(STREPTOCOCCUS AGALACTIAE)

Publications (1)

Publication Number Publication Date
AU5755500A true AU5755500A (en) 2001-01-09

Family

ID=22489677

Family Applications (1)

Application Number Title Priority Date Filing Date
AU57555/00A Abandoned AU5755500A (en) 1999-06-21 2000-06-21 Isolated genes from virulent group B streptococcus agalactiae

Country Status (2)

Country Link
AU (1) AU5755500A (en)
WO (1) WO2000078787A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7128919B2 (en) 2000-08-08 2006-10-31 St. Jude Children's Research Hospital Group B streptococcus polypeptides nucleic acids and therapeutic compositions and vaccines thereof
US7892552B2 (en) 2001-08-08 2011-02-22 University Of Utah Research Foundation Group B Streptococcus polypeptides nucleic acids and therapeutic compositions and vaccines thereof
NZ594877A (en) 2000-10-27 2012-07-27 Novartis Vaccines & Diagnostic Nucleic acids and proteins from streptococcus groups A & B
PT1648500E (en) 2003-07-31 2014-10-10 Novartis Vaccines & Diagnostic Immunogenic compositions for streptococcus pyogenes
US8945589B2 (en) 2003-09-15 2015-02-03 Novartis Vaccines And Diagnostics, Srl Immunogenic compositions for Streptococcus agalactiae
EP2197485B1 (en) 2007-09-12 2015-11-11 GlaxoSmithKline Biologicals SA Gas57 mutant antigens and gas57 antibodies
GB0802503D0 (en) * 2008-02-11 2008-03-19 Novartis Ag Hybrid polypeptide

Also Published As

Publication number Publication date
WO2000078787A1 (en) 2000-12-28
WO2000078787A8 (en) 2001-04-05
WO2000078787A9 (en) 2002-06-27

Similar Documents

Publication Publication Date Title
AU7098000A (en) Signed group criteria
AU2545200A (en) Solid pigment preparations
AU2001295795A1 (en) Streptococcal genes
AU2001232952A1 (en) Charge balancing system
AUPQ262599A0 (en) Gene expression
AU5755500A (en) Isolated genes from virulent group B streptococcus agalactiae
AU6277600A (en) Novel chimeric genes
AU2001242625A1 (en) Gene sequence
AU6417799A (en) Matrix-remodeling genes
EP1144631A3 (en) Insulin-synthesis genes
AU2001264247A1 (en) GASC1 gene
AU4849099A (en) Dbs feature extension architecture
AUPP907599A0 (en) Directional guidewire
AU9567398A (en) Fungal pathogenicity genes
AU2400401A (en) Novel phosphodiesterases and genes thereof
AU2001247444A1 (en) Erbeta-mediated gene expression
AU7567101A (en) Gene expression system
AU2001229768A1 (en) Amplified genes at 17q23
AU7744200A (en) Polyhydroxyalkanoate synthase genes
AU2001285743A1 (en) Adipose-related gene
AU5811600A (en) Vaccine
AU7752100A (en) C3 binding polypeptide of streptococcus agalactiae, group b streptococcus
AU6871900A (en) Tsg-like gene
AU1870000A (en) Gene therapy-2
AU6006100A (en) Plant genes

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase